Article

Identification and Validation of Four Novel Biomarkers Involved in Docetaxel Resistant Prostate Cancer

2021-03-15

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Prostate cancer (PCa) is one of the most common malignancies affecting men’s health. Docetaxel chemotherapy has been utilized in castration resistant prostate cancer (CRPC). However, docetaxel resistance further reduces the survival of PCa patients. Thus, it is necessary to explore effective biomarkers for docetaxel chemotherapy resistant PCa (DCRPC).<bold>Metho...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6f0e8eaf-2019-5222-a401-162639f0c302
DOI: 10.21203/rs.3.rs-298854/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification and Validation of Four Novel Biomarkers Involved in Docetaxel Resistant Prostate CancerDOI 10.21203/rs.3.rs-298854/v1Read

Identification of Key Genes and Molecular Mechanisms Associated With Docetaxel Resistance in Castration Resistant Prostate Cancer Based on Bioinformatics AnalysisSemantic proximity Read

Exploration and Identification of Potential Therapeutic Targets and Biomarkers for Docetaxel Resistant Prostate CancerSemantic proximity Read

Gene Expression Changes and Associated Pathways Involved in the Progression of Prostate Cancer Advanced StagesSemantic proximity Read

Identification of key genes controlling docetaxel resistance in patients with breast cancerSemantic proximity Read

Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAsSemantic proximity Read

Construction and Verification of a Prognostic Model for Prostate Cancer based on Ribosome Biogenesis-Related GenesSemantic proximity Read

Machine Learning-Based Identification of Co-expressed Genes in Prostate Cancer and CRPC and Construction of Prognostic ModelsSemantic proximity Read

Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glanceSemantic proximity Read

Identification of key molecules for castration resistance prostate cancer by bioinformatic analysisSemantic proximity Read

Machine learning-based identification of co-expressed genes in prostate cancer and CRPC and construction of prognostic modelsSemantic proximity Read

The cornerstone of early diagnosis and immunotherapy of prostate cancer:screening characteristic genesSemantic proximity Read

Bioinformatics and system biology approaches for identifying potential therapeutic targets for prostate cancerSemantic proximity Read